Pharmacokinetic Drug‐Drug Interactions Between Trospium Chloride and Ranitidine Substrates of Organic Cation Transporters in Healthy Human Subjects.

MLA

Abebe, Bayew Tsega, et al. “Pharmacokinetic Drug‐Drug Interactions Between Trospium Chloride and Ranitidine Substrates of Organic Cation Transporters in Healthy Human Subjects.” Journal of Clinical Pharmacology, vol. 60, no. 3, Mar. 2020, pp. 312–23. EBSCOhost, https://doi.org/10.1002/jcph.1523.

APA

Abebe, B. T., Weiss, M., Modess, C., Tadken, T., Wegner, D., Meyer, M. J., Schwantes, U., Neumeister, C., Scheuch, E., Schulz, H., Tzvetkov, M., & Siegmund, W. (2020). Pharmacokinetic Drug‐Drug Interactions Between Trospium Chloride and Ranitidine Substrates of Organic Cation Transporters in Healthy Human Subjects. Journal of Clinical Pharmacology, 60(3), 312–323. https://doi.org/10.1002/jcph.1523

Chicago

Abebe, Bayew Tsega, Michael Weiss, Christiane Modess, Tobias Tadken, Danilo Wegner, Marleen J. Meyer, Ulrich Schwantes, et al. 2020. “Pharmacokinetic Drug‐Drug Interactions Between Trospium Chloride and Ranitidine Substrates of Organic Cation Transporters in Healthy Human Subjects.” Journal of Clinical Pharmacology 60 (3): 312–23. doi:10.1002/jcph.1523.